Goodbye to Cancer Pioneer Judah Folkman | GenomeWeb

Cancer researcher Judah Folkman has died, the New York Times reports. Known as the "father of the idea that tumors can be kept in check by choking off the supply of blood they need to grow," his work led to the development of several anti-angiogenic drugs, including Genentech’s Avastin. Dr.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.